共 50 条
- [22] Faster-acting insulin Fiasp versus insulin Novorapid in type 1 diabetes children and adolescents with sensor-augmented pump therapy [J]. HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 182 - 182
- [27] Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden [J]. Diabetes Therapy, 2017, 8 : 1015 - 1030